Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07652606
Clinical Trial
Expanded Access to RGX-202
Temporarily Not Available
View on ClinicalTrials.gov →
Summary
Provide single patient expanded access to RGX-202 for eligible patients
Trial Details
NCT Number
NCT07652606
Lead Sponsor
REGENXBIO Inc.
Updated on ClinicalTrials.gov
2026-06-17